TP53 and B-cell chronic lymphocytic leukemia: In addition to the high-risk and low-risk prognosis markers ZAP70 and IgVH, the 17p deletion in the TP53 gene is also considered a strong independent adverse prognostic factor for survival and is associated with the short median treatment-free survival, in CLL patients with CLL [38].